Business Description
Founded in Switzerland in 1993, BB Biotech AG is an investment fund run by Bellevue Asset Management AG. The fund buys shares in publicly traded companies around the world that develop medicines and diagnostic tools using biotechnology. Investment decisions are guided by in-depth research into each company's underlying business fundamentals.
